Zgierska, Aleksandra E. https://orcid.org/0000-0002-7773-6003
Robinson, James M.
Lennon, Robert P.
Smith, Paul D.
Nisbet, Kate
Ales, Mary W.
Boss, Deanne
Tuan, Wen-Jan
Vidaver, Regina M.
Hahn, David L.
Funding for this research was provided by:
Pfizer (16213567)
Article History
Received: 12 December 2019
Accepted: 15 November 2020
First Online: 28 November 2020
Ethics approval and consent to participate
: The University of Wisconsin-Madison Institutional Review Board determined that this project was a QI initiative, not constituting human subjects research as defined under 45 CFR 46.102(d). The need for consent was, therefore, deemed unnecessary.
: Not Applicable.
: The funding for this study came from a competitive peer-reviewed researcher-initiated unrestricted grant from Pfizer, awarded to the Interstate Postgraduate Medical Association in partnership with the University of Wisconsin; Pfizer was not involved in the design and conduct of this project or the manuscript write-up. Some of the authors (AEZ, JMR, PDS, DB, WJT, RMV, DLH) were employed during the project by the University of Wisconsin (UW); the UW Health primary care clinics were the target for the described QI intervention. In addition, some of the authors have received funding support for scientific projects in the past 3 years from the following external agencies: National Institutes of Health (AEZ), Patient-Centered Outcomes Research Institute (AEZ, WJT), U.S. Department of Justice (AEZ, JMR), Wisconsin Department of Health Services (AEZ), Wisconsin Department of Transportation (JMR), and Pfizer (AEZ).